top of page

Media & Press

Media & Press

All Posts

Synhale Therapeutics Acquires Telaglenastat, Accelerates Development for Pulmonary Hypertension Treatment

Synhale Therapeutics Acquires Telaglenastat, Accelerates Development for Pulmonary Hypertension Treatment

Synhale Therapeutics Acquires Telaglenastat, Accelerates Development for Pulmonary Hypertension Treatment

Media & Press

INFO@SYNHALE.COM

TEL: 617-758-8643

© 2025 by Synhale Therapeutics

Media & Press

bottom of page